Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
Baudin, Eric, Goichot, Bernard, Berruti, Alfredo, Hadoux, Julien, Moalla, Salma, Laboureau, Sandrine, Nölting, Svenja, de la Fouchardière, Christelle, Kienitz, Tina, Deutschbein, Timo, Zovato, Stefania, Amar, Laurence, Haissaguerre, Magalie, Timmers, Henri, Niccoli, Patricia, Faggiano, Antongiulio, Angokai, Moussa, Lamartina, Livia, Luca, Florina, Cosentini, Deborah, Hahner, Stefanie, Beuschlein, Felix, Attard, Marie, Texier, Matthieu, Fassnacht, Martin, DOCAO, Christine, Drui, Delphine, Borson Chazot, Francoise, Chabre, Olivier, Vezzosi, Delphine, Castinetti, Frederic, Bertherat, Jérôme, Libé, Rossella, Gimenez-Roqueplo, Anne Paule, Favier, Judith, Quinkler, Marcus, Strasburger, Christian, Zopf, Katrin, Reincke, Martin, Kroiss, Matthias, Remde, Hanna, Haaf, Michaela, Fuß, Carmina T, Dischinger, Ulrich, Eisenhofer, Graeme, Pamporaki, Christina, Van Berkel, Anouk
Published in The Lancet (British edition) (16.03.2024)
Published in The Lancet (British edition) (16.03.2024)
Get full text
Journal Article
051 - PHASE 2 NIVO-ALCL STUDY OF NIVOLUMAB FOR RELAPSE/REFRACTORY ALK+ALCL, FOR PATIENTS WITH PROGRESSIVE DISEASE OR AS CONSOLIDATIVE IMMUNOTHERAPY AFTER COMPLETE REMISSION
Rigaud, Charlotte, Ibrahimi, Nusaibah, Sibon, David, Nysom, Karsten, Garnier, Nathalie, Ducassou, Stéphane, Vergé, Véronique, Lamant, Laurence, Angokai, Moussa, Oberic, Lucie, Barbati, Melissa, Simonin, Mathieu, Pasquet, Marlène, Couec, Marie-Laure, Amorim, Sandy, Phulpin, Aurélie, Reda, Bouabdallah, Reguerre, Yves, Gros, François-Xavier, Beishuizen, Auke, Burke, GAA, Brugières, Laurence, Auperin, Anne, Minard-Colin, Véronique
Published in Leukemia research (01.09.2025)
Published in Leukemia research (01.09.2025)
Get full text
Journal Article
PHASE 2 NIVO-ALCL STUDY OF NIVOLUMAB FOR RELAPSE/REFRACTORY ALK+ALCL, FOR PATIENTS WITH PROGRESSIVE DISEASE OR AS CONSOLIDATIVE IMMUNOTHERAPY AFTER COMPLETE REMISSION
Rigaud, Charlotte, Ibrahimi, Nusaibah, Sibon, David, Nysom, Karsten, Garnier, Nathalie, Ducassou, Stéphane, Vergé, Véronique, Lamant, Laurence, Angokai, Moussa, Oberic, Lucie, Barbati, Melissa, Simonin, Mathieu, Pasquet, Marlène, Couec, Marie-Laure, Amorim, Sandy, Phulpin, Aurélie, Reda, Bouabdallah, Reguerre, Yves, Gros, François-Xavier, Beishuizen, Auke, Burke, GAA, Brugières, Laurence, Auperin, Anne, Minard-Colin, Véronique
Published in Leukemia research (01.09.2025)
Published in Leukemia research (01.09.2025)
Get full text
Journal Article
Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients
Tao, Yungan, Auperin, Anne, Sire, Christian, Martin, Michel, Saliou, Marie-Gabrielle, Bardet, Etienne, Sun, Xu Shan, Chatellier, Thierry, Morand, Clotilde, Cornely, Alexandre, Angokai, Moussa, Di Rito, Alessia, Kichenin, Ketty, Blanchard, Pierre, D'Onofrio, Ida, Bourhis, Jean
Published in International journal of radiation oncology, biology, physics (01.11.2017)
Published in International journal of radiation oncology, biology, physics (01.11.2017)
Get full text
Journal Article